Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome

American Journal of Hypertension

Volumn 11, Issue 11 I, 1998, Pages 1284-1289

  Peled, Nir ^a   Greenberg, Avital ^b   Pillar, Giora ^a   Zinder, Oren ^b   Levi, Nurit ^b   Lavie, Peretz ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Blood pressure; Catecholamines; Obstructive sleep apnea; Sympathetic system

Indexed keywords

ADRENALIN; CATECHOLAMINE; NORADRENALIN; OXYGEN;

ADRENALIN URINE LEVEL; ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; HUMAN; HYPOXIA; MALE; NORADRENALIN URINE LEVEL; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SLEEP APNEA SYNDROME; SYMPATHETIC TONE;

ADULT; AGED; ANOXIA; BLOOD PRESSURE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; RESPIRATION DISORDERS; SLEEP APNEA SYNDROMES; SYMPATHETIC NERVOUS SYSTEM;

EID: 0031769725     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00159-9     Document Type: Article

References (27)

1. Lavie P., Herer P., Peled R., et al. Mortality in sleep apnea patients a multivariable analysis of risk factors . Sleep. 18:1995;149-157.
2. He J., Kryger M.H., Zorick F.J., Roth T. Mortality and apnea index in obstructive sleep apnea. Chest. 94:1988;9-14.
3. Lavie P., Ben-Yosef R., Rubin A. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J. 108:1984;373-376.
4. Do-Un J., Dimsdale J.E. Sleep apnea and essential hypertension a critical review of the epidemiological evidence for co-morbidity . Clin Exper Hypertens [A]. A11:1989;1301-1323.
5. Kales A., Bixler E.O., Cadieux R.J., et al. Sleep apnea in a hypertensive population. Lancet. 2:1984;1005-1008.
6. Fletcher E.C., DeBehnke R.D., Lovoni M.S., Gorin A.B. Undiagnosed sleep apnea in patients with essential hypertension. Ann Int Med. 103:1985;190-195.
7. Fletcher E.C. The relationship between systemic hypertension and obstructive sleep apnea Facts and theory . Am J Med. 98:1995;118-128.
8. Hoffstein V., Chan C.K., Slutsky A.S. Sleep apnea and systemic hypertension a causal association review . Am J Med. 91:1991;190-196.
9. Eisenberg E., Zimlichman R., Lavie P. Plasma norepinephrine levels in patients with sleep apnea syndrome (letter). N Engl J Med. 322:1990;932-933.
10. Ozaki N., Okada T.I., Ohta T., et al. Plasma norepinephrine in sleep apnea syndrome. Neuropsychobiology. 16:1986;88-92.
11. Fletcher E.C., Miller J., Schaff J.W., Fletch J.G. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep. 10:1987;35-44.
12. Hedner J., Ejnell H., Sellgren J., et al. Is high and fluctuating muscle nerve sympathetic activity in sleep apnea syndrome of pathogenetic importance for the development of hypertension? J Hypertens. 6:(suppl 4):1988;S529-S531.
13. Carlson J.T., Hedner J., Elan M., et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest. 103:1993;1763-1768.
14. Aardweg J.G., Karemaker J.M. Repetitive apnea induced periodic hypertension in normal subjects through hypoxia. J Appl Physiol. 72:1992;821-827.
15. Smith M.L., Niedermaier O.N.W., Hardy S.M., et al. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Sys. 56:1996;184-190.
16. Ringler J., Basner R.C., Shannon R., et al. Hypoxemia alone does not explain blood pressure elevation after obstructive sleep apneas. J Appl Physiol. 69:1990;2143-2148.
17. Morgan B.J., Crabtree D.C., Puleo D.S., et al. Neurocirculatory consequences of abrupt changes in sleep state in humans. J Appl Physiol. 80:1996;1627-1636.
18. Rechtschaffen A, Kales A, eds: A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. UCLA, Brain Information Service/Brain Research, University of California, Los Angeles, 1968.
19. Chugh K.D., Weaver T.E., Dinges D.F. Neurobehavioral consequences of arousals. Sleep. 19:1996;S198-S201.
20. Rodriguez C., Bernard N., Julien C., et al. Routine analysis of catecholamines and metabolites in urine by liquid chromatographic column switching system. Int J Environ Anal Chem. 25:1986;235-255.
21. Clark R.W., Boudoulas H., Schaal S.F., Schmidt H.S. Adrenergic hyperactivity and cardiac abnormality in primary disorders of sleep. Neurology. 30:1980;113-119.
22. Brooks D., Horner R.L., Kozar L.F., et al. Obstructive sleep apnea as a cause of systemic hypertension evidence from a canine model. J Clin Invest. 99:1997;106-109.
23. Lavie P., Yaffe N., Berger I., Peled R. The relationship between the severity of sleep apnea syndrome and 24-h blood pressure values in patients with obstructive sleep apnea. Chest. 103:1993;717-721.
24. Trzebski A. Arterial chemoreceptor reflex and hypertension. Hypertension. 19:1992;562-566.
25. Bing R.F., Harlow J., Smith A.J., Townsend M.M. The urinary excretion of catecholamines and their derivatives in primary hypertension in man. Clin Sci Molec Med. 52:1977;19-23.
26. Townshend M.M., Smith A.J. Factors influencing the urinary excretion of free catecholamines in man. Clin Sci. 44:1973;253-265.
27. Messerli F.H., Glade L.B., Ventura H.O., et al. Diurnal variation of cardiac rhythm, arterial pressure, and urinary catecholamines in borderline and established essential hypertension. Am Heart J. 104:1982;114.